Group 1 - Clarivate PLC (NYSE:CLVT) announced its 2025 Citation Laureates, recognizing 22 researchers for their contributions in various fields, including leukemia research and quantum computing [2] - The program has a strong track record, with 83 Citation Laureates having won Nobel Prizes, indicating Clarivate's influence in global research metrics [2] - Wolfe Research initiated coverage on Clarivate PLC with a "Peer Perform" rating and a year-end fair value range of $4-$5, citing the company's strong market position despite slower stock performance [3] Group 2 - Wolfe Research highlighted potential risks for Clarivate, including tighter academic budgets and the impact of AI disintermediation [3] - Clarivate operates as a global information services provider, delivering data-driven intelligence and analytics across multiple regions, including the Americas, EMEA, and Asia Pacific [4] - The company is listed among the 10 Cheapest Penny Stocks to Buy Now, indicating its current valuation attractiveness [4]
Clarivate PLC (CLVT) Announces its 2025 Citation Laureates; Wolfe Research Initiates Coverage with a “Peer Perform” Rating